Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508504 · ClinicalTrials.gov registry record · NA
PENG Block for Arthroscopic Hip Surgery
A NA study of Postoperative Pain and Hip Arthroscopy, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04508504: Completed NA study of Postoperative Pain and Hip Arthroscopy, sponsored by University of Virginia.
NCT04508504 is a NA study of Postoperative Pain and Hip Arthroscopy that has completed, run by University of Virginia. The registered enrollment target is 70 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04508504, a NA study of Postoperative Pain and Hip Arthroscopy, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.
Primary Outcome
Maximum pain score within the first 30 minutes after emergence in the post-anesthesia care unit. Pain will be assessed by numerical rating score (0-10, where 0 is no pain, and 10 is the worst possible pain).
Conditions Studied
Interventions
- DRUG Ropivacaine 0.5% Injectable Solution
- DRUG Normal Saline
- PROCEDURE Preop PENG block
- PROCEDURE Placebo block
Study Locations (1)
Virginia
- UVA Outpatient Surgery Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2022-02-08 |
| Phase | NA |
What the finished NCT04508504 record still lists
NCT04508504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Ropivacaine 0.5% Injectable Solution is the first listed.
NCT04508504 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04508504 about?
NCT04508504 is a clinical study titled "PENG Block for Arthroscopic Hip Surgery". This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.
What is the current status of trial NCT04508504?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-12-01. Estimated completion is 2022-02-08.
What conditions does trial NCT04508504 study?
This clinical trial studies the following conditions: Postoperative Pain, Hip Arthroscopy.
What interventions are being tested in trial NCT04508504?
The interventions under investigation include: Ropivacaine 0.5% Injectable Solution (DRUG), Normal Saline (DRUG), Preop PENG block (PROCEDURE), Placebo block (PROCEDURE).
Who is sponsoring clinical trial NCT04508504?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04508504 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04508504's enrollment target sits among peer trials
70 86th of 120 higher than 33 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI